Curia (formerly AMRI), a contract research, development and manufacturing organization (CDMO), has adopted The Beacon Optofluidic system and workflows from Berkeley Lights to accelerate and expand its antibody-based drug discovery capabilities.   The Beacon system workflow at Curia leverages its proprietary Pentamice platform, CHO-GSN and TunaCHO platforms, as well as the company’s antibody and cell-line engineering systems.   With the addition of the Beacon system, Curia is able to provide ...